Literature DB >> 27059356

Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.

Enyonam Tsolenyanu1, Jason M Mwenda2, Anoumou Dagnra3, Eyal Leshem4, Mawussi Godonou3, Ibrahim Nassoury5, Dadja Landoh6, Jacqueline E Tate4, Yawo Atakouma1, Umesh D Parashar4.   

Abstract

Togo introduced monovalent rotavirus vaccine starting 19 June 2014. We compared all-cause acute gastroenteritis (AGE) hospitalizations and rotavirus-associated hospitalizations during the prevaccine period (July 2008-June 2014) to 1 year after vaccine introduction (July 2014-June 2015). The proportion of children with AGE who tested positive for rotavirus declined from 53% (645/1223) in prevaccine years to 36% (68/187) in the postvaccine year (P< .01). The decline only occurred in children <1 year of age who were eligible for vaccination and was greatest during the rotavirus season months, supporting that it was associated with vaccine implementation.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Togo; impact; monovalent rotavirus vaccine; rotavirus

Mesh：

Substances：

Year:  2016        PMID： 27059356     DOI： 10.1093/cid/civ1182

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  7 in total

1.  Epidemiology of intussusception among infants in Togo, 2015-2018.

Authors:  Enyonam Tsolenyanu; Komlatsè Akakpo-Numado; Djatougbe Eliane Akolly; Jason Mwenda; Jacqueline Tate; Amevegbe Boko; Dadja Landoh; Komlan Gnassingne; Yawo Atakouma; Umesh Parashar
Journal:  Pan Afr Med J       Date:  2021-07-29

2.  Emergence of G12 and G9 rotavirus genotypes in the Central African Republic, January 2014 to February 2016.

Authors:  Ulrich Aymard Ekomi Moure; Virginie Banga-Mingo; Jean Chrysostom Gody; Jason M Mwenda; Jean Fandema; Diane Waku-Kouomou; Casimir Manengu; Thomas D'Aquin Koyazegbe; Mathew D Esona; Michael D Bowen; Ionela Gouandijka-Vasilache
Journal:  BMC Res Notes       Date:  2018-01-05

3.  Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Authors:  Richard Omore; Sammy Khagayi; Billy Ogwel; Reuben Onkoba; John B Ochieng; Jane Juma; Stephen Munga; Collins Tabu; Sergon Kibet; J Pekka Nuorti; Frank Odhiambo; Jason M Mwenda; Robert F Breiman; Umesh D Parashar; Jacqueline E Tate
Journal:  BMC Infect Dis       Date:  2019-01-11       Impact factor: 3.090

4.  Rotavirus prevalence and seasonal distribution post vaccine introduction in Nairobi county Kenya.

Authors:  Joshua Gikonyo; Betty Mbatia; Patrick Okanya; George Obiero; Carlene Sang; James Nyangao
Journal:  Pan Afr Med J       Date:  2019-07-29

5.  Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.

Authors:  Amadou Diop; Aliou Thiongane; Jason M Mwenda; Negar Aliabadi; Mouhamadou A Sonko; Aliou Diallo; Babacar Ndoye; Papa M Faye; Idrissa D Ba; Umesh D Parashar; Jacqueline E Tate; Ousmane Ndiaye; Moussa F Cissé; Mamadou Ba
Journal:  Vaccine       Date:  2017-11-20       Impact factor: 3.641

6.  Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.

Authors:  Bakary Sanneh; Alhagie Papa Sey; Minesh Shah; Jacqueline Tate; Mariama Sonko; Sheriffo Jagne; ModouLamin Jarju; Dawda Sowe; Makie Taal; Adam Cohen; Umesh Parashar; Jason M Mwenda
Journal:  Vaccine       Date:  2018-03-12       Impact factor: 3.641

7.  Evidence of rotavirus vaccine impact in sub-Saharan Africa: Systematic review and meta-analysis.

Authors:  Opolot Godfrey; Weidong Zhang; Cecilia Amponsem-Boateng; Timothy Bonney Oppong; QingLin Zhao; Dankang Li
Journal:  PLoS One       Date:  2020-04-27       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.